RCL
79
2
FOXA
59
7
XYL
35
2
DVA
59
4
EMR
50
2
LOW
50
4
FRT
36
2
CMA
50
-2
GOOGL
48
-5
NVDA
54
2
RSG
60
3
ROST
54
9
ZTS
27
-9
F
40
5
TAP
51
6
APD
47
-2
CHRW
50
13
D
40
-5
HST
58
11
BBY
43
3
RCL
79
2
FOXA
59
7
XYL
35
2
DVA
59
4
EMR
50
2
LOW
50
4
FRT
36
2
CMA
50
-2
GOOGL
48
-5
NVDA
54
2
RSG
60
3
ROST
54
9
ZTS
27
-9
F
40
5
TAP
51
6
APD
47
-2
CHRW
50
13
D
40
-5
HST
58
11
BBY
43
3
Financhill
Back

Cellectar Biosciences Vs. Perspective Therapeutics Industry Stock Comparison

Sell
38

CLRB
Cellectar Biosciences

Last Price:
2.04
Seasonality Move:
-1.23%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.11
Seasonality Move:
26.28%
Sell
38
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.03. The Score for CLRB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 44.93 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.04 - 2.14) Sell
Bollinger Bands (100): (1.93 - 2.57) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 46.93 Sell
Chaikin Money Flow: -154562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.92 - 13.12) Sell
Bollinger Bands (100): (11.23 - 14.35) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.05 Sell
20-day SMA: 2.07 Sell
50-day SMA: 2.09 Sell
200-day SMA: 2.87 Sell
8-day EMA: 2.05 Sell
20-day EMA: 2.06 Sell
50-day EMA: 2.12 Sell
200-day EMA: 2.51 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.85 Buy
20-day SMA: 12.37 Sell
50-day SMA: 13.45 Sell
200-day SMA: 12.59 Sell
8-day EMA: 12 Buy
20-day EMA: 12.31 Sell
50-day EMA: 12.84 Sell
200-day EMA: 11.76 Buy

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):